| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.43 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |